Tekla Capital Management’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Tekla Capital Management’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-250,000	Closed	-$5.23M	–	154
2016 Q3	$5.23M	Buy	+250,000	New	+$2.88M	0.2%	84

Tekla Capital Management's VTAE Position: Q4 2016 in Review

Tekla Capital Management sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 250,000 shares — an estimated $5.23M sold.

Tekla Capital Management first reported a position in VTAE in Q3 2016 and held it in 1 quarter. The position peaked at $5.23M in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

Tekla Capital Management reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
Tekla Capital Management sold 250,000 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $5.23M.
Tekla Capital Management first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q3 2016 and held it in 1 quarter.
Tekla Capital Management's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $5.23M in Q3 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Tekla Capital Management's 13F filing for Q4 2016, filed 13 Feb 2017.